Phase I/II trial DCVax-Direct in patients with metastatic colon cancer.
Status: Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 11 Feb 2013
Price : $35 *
At a glance
- Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
- Indications Colon cancer; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2013 Planned number of patients changed to 60.
- 21 Nov 2012 New trial record